Tie-up with US rival Bristol Myers would have marked return to big pharma mergers
Finance Financial Times Aug 11, 2026
How investors killed AstraZeneca’s $400bn megadeal
Tie-up with US rival Bristol Myers would have marked return to big pharma mergers
